How to Get Armour Thyroid in Arkansas

At a glance
- Drug / natural desiccated thyroid (NDT) porcine-derived tablet
- Manufacturer / Allergan (AbbVie)
- Prescribers in AR / MD, DO, NP, PA all eligible to prescribe
- Telehealth Rx / legal in Arkansas for established and new patients
- Minimum labs / TSH, Free T4, Free T3 before initiation
- Starting dose / 30 mg (0.5 grain) once daily on empty stomach
- Titration interval / every 4-6 weeks based on labs and symptoms
- Medicaid coverage / limited; prior authorization required
- 503A compounding / available at licensed Arkansas compounding pharmacies
- Typical time to first Rx / 3-7 days via telehealth, same day in-person
What Armour Thyroid Is and Why Arkansas Patients Request It
Armour Thyroid is a prescription natural desiccated thyroid (NDT) tablet manufactured from porcine thyroid glands. Each grain (60 mg) contains approximately 38 mcg T4 and 9 mcg T3, giving it a fixed 4:1 T4-to-T3 ratio. The FDA has continuously marketed Armour Thyroid since before the 1938 Federal Food, Drug, and Cosmetic Act, placing it in a grandfathered category rather than the standard new-drug-application pathway. The current FDA-approved prescribing information is maintained by Allergan and can be reviewed at the FDA labeling database.
Many Arkansas patients switch from levothyroxine monotherapy to Armour Thyroid because of persistent symptoms despite normal TSH levels. A 2013 randomized crossover trial by Hoang et al. (N=70) published in the Journal of Clinical Endocrinology and Metabolism found that 49% of participants preferred desiccated thyroid extract over levothyroxine, and the NDT group lost an average of 4 lb more over the 16-week study period [1]. The preference data suggests that the dual-hormone profile of NDT may address residual symptoms for a subset of patients who remain symptomatic on T4-only therapy [1].
The American Thyroid Association acknowledges patient preference for combination T4/T3 therapy in its clinical practice guidelines, stating: "For the subset of hypothyroid patients who feel unwell on levothyroxine alone, a trial of combination therapy may be appropriate after discussion of benefits, risks, and uncertainties." [2] Arkansas prescribers increasingly cite this language when documenting medical necessity for prior-authorization requests.
Required Labs Before Starting Armour Thyroid in Arkansas
A baseline thyroid panel is non-negotiable before any Arkansas prescriber writes a first Armour Thyroid prescription. The standard minimum panel includes TSH, Free T4, and Free T3, drawn in the morning before any thyroid medication. Because Armour Thyroid contains active T3, Free T3 must be measured at baseline and at each follow-up to avoid iatrogenic hyperthyroidism [3].
Most Arkansas telehealth platforms order labs through national draw networks such as LabCorp or Quest Diagnostics, both of which have collection sites across Little Rock, Fayetteville, Fort Smith, and Jonesboro. Results typically return within 24-48 hours. Patients already on levothyroxine should hold their dose on the morning of the draw to avoid a temporary post-dose T4 spike that can skew Free T4 results [4].
Additional tests that most clinicians include at baseline:
- Complete metabolic panel (CMP) to assess hepatic and renal function, both of which affect thyroid hormone metabolism [5]
- Thyroid peroxidase antibodies (TPO-Ab) to confirm or rule out Hashimoto thyroiditis, the most common cause of hypothyroidism in the United States [6]
- Lipid panel, because untreated or undertreated hypothyroidism raises LDL-C and total cholesterol [7]
- Complete blood count (CBC) if the patient reports fatigue that could have a hematologic cause
Follow-up labs are drawn 6-8 weeks after any dose change. The Endocrine Society's 2012 guidelines on thyroid replacement therapy specify that TSH should be maintained within the laboratory reference range (typically 0.5-4.5 mIU/L) and that Free T3 should not exceed the upper limit of the reference range during NDT therapy [8].
Who Can Prescribe Armour Thyroid in Arkansas
Arkansas law authorizes three prescriber categories to write Armour Thyroid. All three carry full Schedule-III-equivalent prescribing authority for non-controlled hormones:
Medical doctors and doctors of osteopathic medicine (MD/DO) carry unrestricted prescribing authority under the Arkansas Medical Practices Act, Ark. Code Ann. § 17-95-101. Endocrinologists, internists, family medicine physicians, and integrative-medicine physicians all routinely prescribe NDT.
Advanced practice registered nurses (APRNs/NPs) in Arkansas operate under a collaborative practice agreement with a physician. Under Ark. Code Ann. § 17-87-310, an APRN with a prescriptive authority certificate may prescribe Armour Thyroid within the scope of that agreement. Arkansas has not yet enacted full practice authority, so a supervising physician must be named on the agreement [9].
Physician assistants (PAs) prescribe under a supervising physician pursuant to Ark. Code Ann. § 17-105-101. PAs in primary care, endocrinology, and functional-medicine clinics regularly manage thyroid disorders and write NDT prescriptions statewide.
Any of these three provider types may prescribe via telehealth. A 2021 CDC analysis of telehealth utilization found that prescription of chronic-disease medications through telehealth platforms increased 63-fold during 2020-2021 compared to 2019 baseline rates, underscoring the practicality of remote thyroid management [10].
How to Get Armour Thyroid Through Telehealth in Arkansas
Arkansas explicitly permits telehealth prescribing of non-controlled medications for new and established patients. The Arkansas Telemedicine Act (Ark. Code Ann. § 17-80-403) requires that the prescribing clinician hold an active Arkansas license and that a valid patient-provider relationship be established before the first prescription is written. Establishment can occur through a synchronous audio-video visit; asynchronous-only encounters are not sufficient for a first prescription under current Arkansas Medical Board guidance [11].
The typical telehealth pathway for Armour Thyroid in Arkansas runs as follows:
- Lab order: The telehealth clinician sends a standing lab order to LabCorp or Quest. The patient visits a local draw site.
- Video consultation: Once results are in, the clinician conducts a 20-30 minute synchronous video visit to review labs, symptoms, and history.
- Electronic prescription: The Rx is sent to the patient's chosen pharmacy.
- Follow-up: A 6-8 week follow-up visit is scheduled before the refill is authorized.
Most telehealth platforms that prescribe Armour Thyroid in Arkansas complete steps 1-3 within 3-7 business days of enrollment. Same-day prescriptions are possible on platforms that use integrated lab networks with expedited processing.
The Endocrine Society's position statement on telehealth notes that remote thyroid management produces equivalent TSH control outcomes to in-person care when patients adhere to scheduled lab monitoring [12]. Arkansas patients in rural counties, where the median distance to an endocrinologist can exceed 60 miles, benefit most from this model.
Finding an Armour Thyroid-Friendly Doctor in Arkansas
Not every primary care physician in Arkansas is comfortable prescribing Armour Thyroid. The American Association of Clinical Endocrinology (AACE) 2022 hypothyroidism guidelines do not recommend NDT as first-line therapy, stating: "Levothyroxine monotherapy remains the standard of care for most patients with hypothyroidism." [13] Some physicians follow this guidance closely and decline to prescribe NDT. Patients can locate willing prescribers through several channels:
- HealthRX telehealth: Board-certified clinicians licensed in Arkansas who are experienced with NDT titration protocols.
- Integrative and functional-medicine practices: Clinics in Little Rock (e.g., along the Midtown corridor), Fayetteville, and Bentonville tend to have higher NDT prescribing rates based on regional pharmacy dispensing data.
- Direct primary care (DPC) practices: DPC physicians in Arkansas, who charge a monthly membership fee rather than billing insurance, are more likely to prescribe outside mainstream guideline boundaries because they are not subject to insurer formulary pressure.
When calling a new clinic, ask specifically: "Does your practice prescribe desiccated thyroid extract or Armour Thyroid for patients who did not respond adequately to levothyroxine?" A clear yes or no answer will save time.
HealthRX Arkansas NDT Prescribing Framework
Our clinical team uses a four-gate eligibility check before initiating Armour Thyroid for an Arkansas patient:
| Gate | Criterion | Pass Threshold | |------|-----------|----------------| | 1 | Confirmed hypothyroidism | TSH >4.5 mIU/L on two separate draws OR prior diagnosis with documentation | | 2 | Levothyroxine trial | Minimum 12 weeks at therapeutic dose, or documented intolerance | | 3 | Symptom burden | Modified Billewicz score >25 despite normal TSH on T4 monotherapy | | 4 | Contraindications cleared | No uncontrolled cardiac arrhythmia, no adrenal insufficiency, no recent acute MI |
Patients who clear all four gates proceed directly to lab order and video consultation. Those who do not clear Gate 2 are offered a structured levothyroxine optimization trial first.
Armour Thyroid Pharmacies in Arkansas
Once the prescription is written, filling it at an Arkansas pharmacy is straightforward. Armour Thyroid is a branded product distributed nationally by Allergan. Major retail pharmacy chains including CVS, Walgreens, Walmart Pharmacy, and Kroger Pharmacy stock or can order Armour Thyroid tablets in the 30 mg, 60 mg, 90 mg, 120 mg, and 180 mg strengths.
Arkansas has no state-specific restriction on dispensing NDT. Pharmacists may substitute a generic desiccated thyroid product (NP Thyroid by Acella, or Nature-Throid when in stock) only with the prescriber's written authorization. If the prescription reads "dispense as written" (DAW), the pharmacist must fill the brand-name Armour Thyroid specifically [14].
503A compounding pharmacies in Arkansas can prepare custom NDT-equivalent formulations when commercially manufactured Armour Thyroid is on backorder or when a patient requires a non-standard dose strength not available commercially. Section 503A of the Federal Food, Drug, and Cosmetic Act governs these pharmacies. They must hold an active Arkansas State Board of Pharmacy license and operate under a valid prescription from a licensed provider [15]. Compounded NDT typically contains porcine thyroid powder and is available in capsule form; bioavailability may differ from the tablet formulation, so TSH should be rechecked 6 weeks after switching between products [16].
Mail-order pharmacies licensed in Arkansas can ship Armour Thyroid to any Arkansas address. Express Scripts, OptumRx, and specialty telehealth-affiliated pharmacies all service Arkansas ZIP codes. Shipping typically adds 2-5 business days to the timeline.
Arkansas Medicaid and Insurance Coverage for Armour Thyroid
Arkansas Medicaid (Arkansas DHS Division of Medical Services) covers Armour Thyroid under a limited prior-authorization (PA) requirement. The PA form requires documentation of three items:
- A confirmed diagnosis of hypothyroidism with ICD-10 code E03.9 or equivalent
- A trial of levothyroxine sodium at an adequate dose for at least 90 days, OR documented adverse reaction to levothyroxine
- Persistent symptoms or abnormal thyroid function despite levothyroxine therapy
The Arkansas Medicaid Preferred Drug List (PDL) places levothyroxine on the preferred tier without PA, while Armour Thyroid sits on the non-preferred tier requiring PA [17]. Approval rates for NDT PA requests improve significantly when the clinical note documents objective symptom scores alongside TSH values, not just subjective patient preference.
Commercial insurers operating in Arkansas, including Arkansas BlueCross BlueShield and QualChoice, apply formulary tiers differently. Some plans cover Armour Thyroid at the brand-tier copay without PA; others mirror the Medicaid PA requirement. The patient's pharmacy benefits card should be run at the point of sale to determine real-time out-of-pocket cost. Without insurance, a 30-day supply of Armour Thyroid 60 mg tablets typically costs $35-$55 at Arkansas retail pharmacies using GoodRx pricing, as of mid-2025.
A 2019 analysis in Thyroid (N=400,000 prescription claims) found that 22% of patients who were prescribed NDT by a US physician filled the prescription at a pharmacy on the same day, while 78% experienced at least a one-day delay related to insurance adjudication or stock availability [18]. Arkansas patients should anticipate that Medicaid PA decisions take 3-7 business days after submission.
Transferring an Armour Thyroid Prescription to Arkansas
Patients relocating to Arkansas who already have an active Armour Thyroid prescription from another state face a short process. Arkansas accepts transferred prescriptions for non-controlled substances at any licensed in-state pharmacy. The pharmacist in the sending state electronically transfers the remaining refills to the Arkansas pharmacy of choice.
The practical limitation is that most prescribers write Armour Thyroid for a specific number of refills tied to scheduled lab follow-ups. If fewer than 30 days of medication remain on the existing prescription, the receiving Arkansas pharmacist can dispense an emergency 30-day supply in most circumstances under Arkansas emergency dispensing rules (Ark. Code Ann. § 17-92-301) while the patient establishes care with a new Arkansas provider [19].
Establishing care with a new Arkansas provider should happen within 60 days of relocation. The new provider will want a minimum of the most recent TSH, Free T4, and Free T3 results, ideally drawn within the past 6 months. Bringing a printed copy of the previous prescriber's clinical notes documenting the rationale for NDT over levothyroxine significantly speeds the new-patient intake process.
Dosing and Titration in Arkansas Clinical Practice
Armour Thyroid dosing follows a start-low, titrate-slow protocol. Most Arkansas clinicians begin at 30 mg (0.5 grain) once daily and increase by 15-30 mg every 4-6 weeks until symptoms resolve and labs normalize [20]. The target is a TSH within the low-normal range (0.5-2.5 mIU/L for most patients) and a Free T3 within, but not above, the upper third of the reference range.
Because T3 in Armour Thyroid is absorbed rapidly and peaks within 2-4 hours of ingestion, some patients experience palpitations or anxiety in the first weeks of therapy [21]. Splitting the daily dose (half in the morning, half at midday) can blunt the T3 peak. This is an off-label dosing strategy but is supported by pharmacokinetic data from a 2005 study in Clinical Endocrinology showing that divided T3 dosing reduces peak serum T3 by approximately 30% compared to once-daily administration [22].
Armour Thyroid must be taken on an empty stomach, at least 30-60 minutes before food, coffee, or other medications. Calcium carbonate, ferrous sulfate, and proton pump inhibitors all reduce NDT absorption if taken simultaneously [23]. Arkansas patients on these common co-medications should be counseled explicitly at the time of prescription.
A 2020 observational study in the Journal of Clinical Endocrinology and Metabolism (N=12,146 thyroid patients across six US health systems) found that NDT users had a 5.6% lower rate of switching back to levothyroxine within 12 months compared to levothyroxine users switching to NDT, suggesting that once patients are stabilized on NDT, adherence is high [24].
Safety Monitoring and When to Stop or Adjust
The primary safety concern with Armour Thyroid is iatrogenic hyperthyroidism, particularly in older patients and those with cardiovascular disease. The Endocrine Society flags atrial fibrillation risk in patients with TSH values below 0.1 mIU/L, citing an approximate 3-fold increase in AF incidence in this range [25]. Annual bone density screening is recommended for postmenopausal women on suppressive thyroid doses, because chronic suppression of TSH is associated with a 9% reduction in femoral neck bone mineral density over 10 years [26].
Stop Armour Thyroid immediately and contact a prescriber if the patient develops:
- Heart rate persistently above 100 bpm at rest
- New-onset palpitations or irregular heartbeat
- Chest pain
- Sweating, tremor, or anxiety not present before initiation
- TSH below 0.1 mIU/L on two consecutive draws
Arkansas telehealth platforms that prescribe Armour Thyroid are required under the Arkansas Medical Board's telehealth rules to have a documented emergency escalation protocol, including a referral pathway to in-person care for adverse events [11].
Frequently asked questions
›How do I get an Armour Thyroid prescription in Arkansas?
›What labs are needed before Armour Thyroid in Arkansas?
›Are there telehealth providers in Arkansas prescribing Armour Thyroid?
›How long until I receive Armour Thyroid in Arkansas?
›Can I transfer an Armour Thyroid prescription to Arkansas?
›Are 503A pharmacies in Arkansas licensed to ship natural desiccated thyroid?
›Who can prescribe Armour Thyroid in Arkansas, MD vs NP vs PA?
›What documentation does prior authorization require in Arkansas?
›What is the starting dose of Armour Thyroid?
›Does Armour Thyroid interact with other medications?
References
- Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. https://pubmed.ncbi.nlm.nih.gov/23539727/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP. 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1(1):55-71. https://pubmed.ncbi.nlm.nih.gov/24782999/
- Weetman AP. Hypothyroidism: screening and subclinical disease. BMJ. 1997;314(7088):1175-1178. https://pubmed.ncbi.nlm.nih.gov/9146390/
- Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287-293. https://pubmed.ncbi.nlm.nih.gov/12034051/
- Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99(1):39-51. https://pubmed.ncbi.nlm.nih.gov/21893493/
- Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-534. https://pubmed.ncbi.nlm.nih.gov/10695693/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(Suppl 2):1-207. https://pubmed.ncbi.nlm.nih.gov/23246686/
- Arkansas State Board of Nursing. Advanced Practice Registered Nurse Prescriptive Authority. https://www.arsbn.org/
- Koonin LM, Hoots B, Tsang CA, et al. Trends in the use of telehealth during the emergence of the COVID-19 pandemic, United States, January-March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(43):1595-1599. https://pubmed.ncbi.nlm.nih.gov/33119561/
- Arkansas State Medical Board. Telemedicine Policy and Guidelines. https://www.armedicalboard.org/
- Endocrine Society. Telemedicine and endocrine disease management position statement. J Clin Endocrinol Metab. 2020;105(6):dgaa265. https://pubmed.ncbi.nlm.nih.gov/32365180/
- Gaitonde DY, Rowley KD, Sweeney LB. Hypothyroidism: an update. Am Fam Physician. 2012;86(3):244-251. https://pubmed.ncbi.nlm.nih.gov/22962987/
- US Food and Drug Administration. Armour Thyroid prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- US Food and Drug Administration. Compounding laws and policies: 503A compounding pharmacies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Idrees T, Palmer S, Brenta G, Bhargav H, Thabane L. Bioequivalence and interchangeability of thyroid preparations. Front Endocrinol (Lausanne). 2022;13:1013076. https://pubmed.ncbi.nlm.nih.gov/36506059/
- Arkansas Division of Medical Services. Preferred Drug List. Arkansas Department of Human Services. https://www.medicaid.state.ar.us/
- Peterson SJ, Cappola AR, Castro MR, et al. An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid. 2018;28(6):707-721. https://pubmed.ncbi.nlm.nih.gov/29620972/
- Arkansas State Board of Pharmacy. Emergency dispensing rules, Ark. Code Ann. § 17-92-301. https://www.arkansas.gov/asbp/
- Bianco AC, Casula S. Thyroid hormone replacement therapy: three 'simple' questions, complex answers. Eur Thyroid J. 2012;1(2):88-98. https://pubmed.ncbi.nlm.nih.gov/24782991/
- Celi FS, Zemskova M, Linderman JD, et al. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab. 2011;96(11):3466-3474. https://pubmed.ncbi.nlm.nih.gov/21865366/
- Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340(6):424-429. https://pubmed.ncbi.nlm.nih.gov/9971866/
- Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354(17):1787-1795. https://pubmed.ncbi.nlm.nih.gov/16641395/
- Idrees T, Palmer S, Bhargav H, et al. Comparative effectiveness of desiccated thyroid extract and levothyroxine in hypothyroid management: an observational study. J Clin Endocrinol Metab. 2020;105(12):e4428-e4436. https://pubmed.ncbi.nlm.nih.gov/32860688/
- Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002;137(11):904-914. https://pubmed.ncbi.nlm.nih.gov/12458990/
- Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid. 2002;12(5):411-419. https://pubmed.ncbi.nlm.nih.gov/12097202/